RecruitingNCT06236945

HUTT to Assess Cardiac Autonomic Nervous Function

Composite Autonomic Scoring Scale and HUTT to Assess Cardiac Autonomic Nervous Function: A Preliminary Study


Sponsor

The First Hospital of Hebei Medical University

Enrollment

1,122 participants

Start Date

Jan 31, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Autonomic nervous system diseases can cause abnormalities in the circulatory system, leading to malignant arrhythmia and sudden cardiac death. Standardized, operable, and simplified diagnostic indicators are urgently needed to evaluate autonomic nervous function, particularly cardiac autonomic nervous function. The investigators use HUTT in order to provide data support for cardiac autonomic nervous system evaluation.


Eligibility

Min Age: 12 YearsMax Age: 85 Years

Inclusion Criteria2

  • Vertical tilt test and 24-hour holter electrocardiogram were performed at the same time
  • Receive treatment in our hospital.

Exclusion Criteria3

  • Taking benzodiazepines or hypotensive drugs within 24 hours
  • Combined with mental illness, severe dementia, serious organ disease
  • Severe arrhythmia, deep breathing and poor coordination of Valsaval movements affected the interpretation of results.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

The First Hospital Of Hebei Medical University

Shijiazhuang, Hebei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06236945


Related Trials